1h Free Analyst Time
Technavio has been monitoring the heparin market and is poised to grow by $3009.44 million from 2023-2027, accelerating at a CAGR of 6.94% during the forecast period. Our report on the heparin market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of coagulation disorders, the increasing prevalence of chronic conditions, and the reintroduction of alternative sources to produce heparin.
The heparin market is segmented as below:
By Product
- Low-molecular-weight heparin
- Others
By Route of Administration
- Subcutaneous injection
- Intravenous/infusion
By Geographical Landscape
- Europe
- North America
- Asia
- Rest of World (ROW)
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the heparin market covers the following areas:
- Heparin market sizing
- Heparin market forecast
- Heparin market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by Route of Administration
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The analyst recognizes the following companies as the key players in the global heparin market: Aspen Pharmacare Holdings, B. Braun SE, Baxter International Inc., Dr Reddys Laboratories Ltd., Eisai Co. Ltd., Fresenius SE and Co. KGaA, Hebei Changshan Biochemical, Hikma Pharmaceuticals Plc, Laboratorios Farmaceuticos Rovi, LEO Pharma AS, Nanjing Kingfriend Biochemical, Nichi Iko Pharmaceutical Co. Ltd., Novartis AG, Opocrin SpA, Pfizer Inc., Sanofi SA, Shanghai Fosun Pharmaceutical Group Co. Ltd., Shenzhen Techdow Pharmaceutical, Teva Pharmaceutical Industries Ltd., and Viatris Inc.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is increasing R&D activities and new therapeutic applications of heparin.'
According to the report, one of the major drivers for this market is the increasing prevalence of coagulation disorders.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Aspen Pharmacare Holdings Ltd
- B.Braun SE
- Baxter International Inc.
- Dr Reddys Laboratories Ltd.
- Eisai Co. Ltd.
- Fresenius SE and Co. KGaA
- Hebei Changshan Biochemical
- Hikma Pharmaceuticals Plc
- Laboratorios Farmaceuticos ROVI S A
- LEO Pharma AS
- Nanjing Kingfriend Biochemical
- Nichi Iko Pharmaceutical Co. Ltd.
- Novartis AG
- Pfizer Inc.
- Sanofi SA
- Shanghai Fosun Pharmaceutical Group Co. Ltd.
- Shenzhen Techdow Pharmaceutical
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.
- Opocrin SpA
